Загрузка...
An atlas of histone deacetylase expression in breast cancer: fluorescence methodology for comparative semi-quantitative analysis
The histone deacetylase inhibitors, suberoylanilide hydroxamic acid (Vorinostat, Zolinza™) and depsipeptide (Romidepsin, Istodax™) have been approved by the US Food and Drug Administration for the treatment of refractory cutaneous T-cell lymphoma. Numerous histone deacetylase inhibitors are currentl...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
e-Century Publishing Corporation
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3276375/ https://ncbi.nlm.nih.gov/pubmed/22347520 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|